Specialty is the future of cost management.
It will soon account for half of U.S. drug spend.
Specialty drug spending is expected to exceed $270 billion in 2022.1 Payers need a strategic partner to meet this challenge.
1. Drug Channels Institute, Adam Fein, “The 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers,” Exhibit 70, February 2018.